|
|||||||||||||||||||||||
Clinical Symptoms
|
If a patient is suspected of having viral encephalitis, a full microbiological examination is required, including: serologic studies, viral cultures, and examination by PCR (polymerase chain reaction).
For more info,link toMedscape: Diagnosis and Management of Viral Encephalitis
Various enzyme-linked immunosorbent assays (ELISA) can be used for antibody detection.
Early in the infection, specific monoclonal antibodies (Mabs) can be used.
Virus identification can be helpful for determining viruses in serum, cerebrospinal fluid and mosquitoes. Commonly used assays include: Mabs for use in IFA assays, Mabs with high avidities for binding in complex protein mixtures, and PCR tests.
For more info, link to the CDC: Info
on Arborial Encephalitides
There are no specific anti-viral drugs for West Nile encephalitis. Instead, supportive therapy is used which deals with the problems that can arise in severe cases of the disease. Therapy can consist of antipyretics to reduce fever (eg. Tylenol), IV fluids, anti-convulsants, and other supportive measures to deal with swelling in the brain, loss of automatic breathing activity, bacterial infection. etc.
In babies and seniors, the prognosis for encephalitis can
be fatal. In other age groups, recovery can be slow. Patients
with severe cases of encephalitis should be kept in a skilled
nursing unit and assessed regularly for level of consciousness
and potential complications.
Mortality rate: 3% to 15% (higher in younger and older age groups)
No cases were recorded in the USA prior to September 1999.
No reliable data are available regarding numbers of cases
of the West Nile virus world-wide.